Eugenie R Lumbers

7PUBLICATIONS
21CO-AUTHORS
Medical infection agents (incl. prions)Human impacts of climate change and human adaptationCancer therapy (excl. chemotherapy and radiation therapy)Automated software engineeringPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 24, 2025
miR-155 suppresses angiotensin II type 1 receptor synthesis during placental morphogenesis.

Anya L Arthurs, Eugenie R Lumbers, Lachlan Schofield

|Oct 16, 2025
Angiotensin-converting enzyme 2 regulates the placental response to repeated hypoxia-reoxygenation insult.

India A Brooker, Jessie M Sutherland, Saije K Endacott

|Feb 02, 2022
Systems analysis shows that thermodynamic physiological and pharmacological fundamentals drive COVID-19 and response to treatment.

Richard J Head, Eugenie R Lumbers, Bevyn Jarrott

|Feb 02, 2022
The interacting physiology of COVID-19 and the renin-angiotensin-aldosterone system: Key agents for treatment.

Eugenie R Lumbers, Richard Head, Gary R Smith

|Jan 14, 2022
"LONG COVID"-A hypothesis for understanding the biological basis and pharmacological treatment strategy.

Bevyn Jarrott, Richard Head, Kirsty G Pringle

|Oct 20, 2021
ACE2: a key modulator of the renin-angiotensin system and pregnancy.

Sonia Tamanna, Eugenie R Lumbers, Saije K Morosin

Pageof 2